APOC2 Gene

APOC2 Gene

Introduction

Apoc2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@supsup2003]
<table> [@supsup2007]
<tr><th>Gene Symbol</th><td>APOC2</td></tr> [@supsup2020]
<tr><th>Full Name</th><td>Apolipoprotein C-II</td></tr> [@supsup2015]
<tr><th>Chromosomal Location</th><td>19q13.32</td></tr>
<tr><th>NCBI Gene ID</th><td>344</td></tr>
<tr><th>OMIM</th><td>207750</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000134901</td></tr>
<tr><th>UniProt ID</th><td>P02655</td></tr>
<tr><th>Protein Length</th><td>79 amino acids</td></tr>
<tr><th>Protein Class</th><td>Apolipoprotein</td></tr>
<tr><th>Associated Diseases</th><td>Hypertriglyceridemia, Alzheimer's Disease, Cardiovascular Disease, Type 2 Diabetes</td></tr>
</table>
</div>

Overview

APOC2 Gene

Introduction

Apoc2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@supsup2003]
<table> [@supsup2007]
<tr><th>Gene Symbol</th><td>APOC2</td></tr> [@supsup2020]
<tr><th>Full Name</th><td>Apolipoprotein C-II</td></tr> [@supsup2015]
<tr><th>Chromosomal Location</th><td>19q13.32</td></tr>
<tr><th>NCBI Gene ID</th><td>344</td></tr>
<tr><th>OMIM</th><td>207750</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000134901</td></tr>
<tr><th>UniProt ID</th><td>P02655</td></tr>
<tr><th>Protein Length</th><td>79 amino acids</td></tr>
<tr><th>Protein Class</th><td>Apolipoprotein</td></tr>
<tr><th>Associated Diseases</th><td>Hypertriglyceridemia, Alzheimer's Disease, Cardiovascular Disease, Type 2 Diabetes</td></tr>
</table>
</div>

Overview

Apolipoprotein C-II (APOC2) is a small 79-amino acid glycoprotein that is a component of very-low-density lipoproteins (VLDL) and high-density lipoproteins (HDL). APOC2 serves as an essential cofactor for lipoprotein lipase (LPL), the enzyme responsible for hydrolyzing triglycerides in circulating lipoproteins. Deficiency in APOC2 leads to severe hypertriglyceridemia (type I hyperlipoproteinemia), while altered APOC2 expression has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), cardiovascular disease, and metabolic disorders.[@supsup1985]

Gene Structure

The APOC2 gene:

• Located on chromosome 19q13.32
• Contains 4 exons spanning approximately 3.3 kb
• Encodes a preproprotein that undergoes signal peptide cleavage
• Expressed primarily in the liver and small intestine

Gene Expression Regulation

APOC2 expression is regulated by:

• Nutritional status: Increased by high-carbohydrate diets
• Insulin: Suppresses APOC2 expression
• PPAR agonists: Fibrates modulate APOC2 levels
• Inflammatory cytokines: TNF-α and IL-6 reduce expression

Protein Structure

APOC2 is a small apolipoprotein with:

Structure-Function Relationships

• The central region (residues 21-55) contains the LPL-activating domain
• Positively charged residues facilitate interaction with negatively charged LPL
• Amphipathic helix structure allows lipoprotein association

Normal Function

Lipoprotein Metabolism

APOC2 plays a central role in triglyceride metabolism:[@supsup2003]

Physiological Roles

• Plasma triglyceride homeostasis: Maintains circulating TG levels
• Lipid transport: Facilitates lipid movement between tissues
• Energy distribution: Delivers fatty acids to peripheral tissues

Expression Pattern

Tissue Distribution

• Liver: Highest expression - primary production site
• Intestine: Contributes to dietary lipid absorption
• Adipose tissue: Minor production
• Brain: Low expression - function unclear

Brain Expression

Recent studies suggest APOC2 may have CNS functions:

• Expressed in [neurons](/entities/neurons) and [astrocytes](/entities/astrocytes)
• May regulate lipid transport in the brain
• Potential role in neuroprotection

Disease Associations

Hypertriglyceridemia

APOC2 deficiency causes:[@supsup2007]

• Severe fasting hypertriglyceridemia (1000-2000 mg/dL)
• Eruptive xanthomas
• Pancreatitis risk
• Lipemia retinalis

Alzheimer's Disease

APOC2 is implicated in AD pathogenesis:[@supsup2020]

• Lipid dysregulation: Altered APOC2 in AD brain
• Amyloid relationship: [APOE](/proteins/apoe-protein) interactions affect [Aβ](/proteins/amyloid-beta) clearance
• Vascular contributions: Modulates cerebral amyloid angiopathy
• Inflammation: Links lipid metabolism to neuroinflammation
• Therapeutic target: Modulating APOC2 may influence AD progression

Cardiovascular Disease

• Atherosclerosis: APOC2 effects on triglyceride-rich lipoproteins
• Coronary artery disease: Association with CAD risk
• Stroke: Independent stroke risk factor

Type 2 Diabetes

• Insulin resistance: APOC2 correlates with insulin sensitivity
• Metabolic syndrome: Elevated APOC2 in metabolic syndrome
• Therapeutic implications: Targeting APOC2 in diabetes

Molecular Mechanisms

LPL Activation Mechanism

APOC2 activates LPL through:

Signaling Pathways

APOC2 influences several pathways:

| Pathway | Effect | Relevance |
|---------|--------|-----------|
| PPARα | Lipid-induced activation | TG metabolism |
| Insulin signaling | Suppression by insulin | Metabolic regulation |
| Inflammatory [NF-κB](/entities/nf-kb) | Cytokine-mediated regulation | Neuroinflammation |

Therapeutic Implications

Treatment Strategies

| Approach | Mechanism | Status |
|----------|-----------|--------|
| LPL gene therapy | AAV-LPL for deficiency | Approved (Glybera) |
| APOC2 mimetics | Synthetic APOC2 peptides | Preclinical |
| Antisense oligonucleotides | Reduce APOC2 (for high TG) | Phase II |
| RNAi | Knockdown of APOC2 | Research |

Alzheimer's Disease

APOC2 as a therapeutic target for AD:

• APOC2 modulators: Could affect Aβ metabolism
• Lipid homeostasis: Restoring brain lipid balance
• Vascular health: Reducing CAA risk
• Combination approaches: With anti-amyloid therapies

Animal Models

• APOC2 knockout mice: Show mild hypertriglyceridemia
• Transgenic APOC2: Overexpression lowers plasma TG
• Humanized models: Expressing human APOC2

See Also

• [APOC2 Protein](/proteins/apoc2-protein)
• [APOC1 Gene](/proteins/apoc1-protein) - Related apolipoprotein
• [APOE Gene](/proteins/apoe) - Major AD risk gene
• [Lipid Metabolism in Neurodegeneration](/mechanisms/sphingolipid-metabolism))
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Cardiovascular Disease and Neurodegeneration](/mechanisms/vascular-contributions-to-neurodegeneration)
• [Triglyceride Metabolism](/mechanisms/triglyceride-metabolism)

External Links

• [NCBI Gene: APOC2](https://www.ncbi.nlm.nih.gov/gene/344)
• [UniProt: APOC2](https://www.uniprot.org/uniprot/P02655)
• [OMIM: APOC2](https://www.omim.org/entry/207750)
• [GeneCards: APOC2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOC2)

Background

The study of Apoc2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

PMID: 3897512(https://pubmed.ncbi.nlm.nih.gov/3897512/) PMID: 12840658(https://pubmed.ncbi.nlm.nih.gov/12840658/) PMID: 17804845(https://pubmed.ncbi.nlm.nih.gov/17804845/) PMID: 32651328(https://pubmed.ncbi.nlm.nih.gov/32651328/) PMID: 25666403(https://pubmed.ncbi.nlm.nih.gov/25666403/)

Pathway Diagram

The following diagram shows the key molecular relationships involving APOC2 Gene discovered through SciDEX knowledge graph analysis: